Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Biochem Pharmacol ; 193: 114785, 2021 11.
Artigo em Inglês | MEDLINE | ID: mdl-34562469

RESUMO

A tryptophan-2,3-dioxygenase 2 (TDO2)-targeted Pt(IV) prodrug, DN604-TDOi, was designed to prove that the multi-action compound could overcome drug resistance and relieve immunosuppression via introducing a TDO2 inhibitor to the axial position of a six-coordinate Pt(IV) hybrid. Several in vitro biological studies on cisplatin-resistant NSCLC cancer cells suggested that TDO2-targeted Pt(IV) prodrug could combat cisplatin resistance via influencing TDO2-kynurenine (Kyn)-aryl hydrocarbon receptor (AhR)-Aquaporin-4 (AQP4) metabolic circuity and AhR-human DNA polymerase (hpol) κ-induced translesion DNA synthesis (TLS) genomic instability, which are positive in drug-resistant human tumors associated with malignant progression and poor survival. Remarkably, we observed that DN604-TDOi could inhibit TDO2-mediated constitutive Kyn-AhR-AQP4 signaling pathway and suppress hpol κ expression, leading to potential decrease of cell motility and genomic instability in A549/cDDP cells. It was confirmed that TDO2-targeted Pt(IV) prodrug could harness Kyn-AhR-AQP4 metabolic circuitry and TLS genomic instability, exerting antitumor effects in C57BL6 but not TDO2-/- mice. Moreover, the Pt(IV) prodrug improved the intratumoral infiltration of Teff cells and reduced the recruitment of Treg cells. The results provided compelling preclinical evidence that TDO2-targeted Pt(IV) prodrug could abrogate immune chemotherapeutic resistance via decaying TDO2-mediated Kyn-AhR-AQP4 immunosuppression and AhR-hpol κ-induced TLS genomic instability, underscoring the development of a novel Pt(IV)-based candidate as a potent immunotherapeutic agent for chemo-immune resistance prevention.


Assuntos
Antineoplásicos/uso terapêutico , Resistencia a Medicamentos Antineoplásicos , Triptofano Oxigenase/antagonistas & inibidores , Células A549 , Adenocarcinoma de Pulmão/tratamento farmacológico , Carboplatina/análogos & derivados , Carboplatina/química , Carboplatina/farmacologia , Sobrevivência Celular , Cisplatino/farmacologia , Humanos , Neoplasias Pulmonares/tratamento farmacológico , Compostos de Platina , Triptofano Oxigenase/genética , Triptofano Oxigenase/metabolismo
2.
Polymers (Basel) ; 10(7)2018 Jul 02.
Artigo em Inglês | MEDLINE | ID: mdl-30960652

RESUMO

Cafferic acid-O-methyltransferases (COMT) down-regulated transgenic and wild-type switchgrass were separated into lignocresols (LCs) and sugars by a phase separation method involving 72% sulfuric acid and cresol. The isolated LCs were characterized by FTIR, GPC, ¹H NMR and 2D-HSQC to understand potential structural modification caused by transgenic engineering lignin or phase separation treatment. No significant changes were found in terms of molecular weights and the amount of incorporated p-cresols between transgenic and wild-type switchgrass LCs. However, the compositions, ratios of syringyl (S) units to guaiacyl (G) units, were changed significantly leading to decrease in S units and increase in G units for transgenic switchgrass LC. The benzodioxane structures and 5-hydroxyguaiacyl units were observed in the 2D-HSQC implied that 5-hydroxyconiferyl alcohol was incorporated into lignin as a result of COMT-down-regulation in the transgenic process.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA